IP Library Granted Patent US 10,226,485
Granted Patent B2
US 10,226,485 · App. 11/084,256 · Granted Mar 12, 2019

Multipotent adult stem cells and methods for isolation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,226,485
App. No.
11/084,256
Granted
Mar 12, 2019
Kind
B2
Abstract

The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells.

Claims (5)

1. A cell culture comprising isolated expanded human non-embryonic, non-germ cells, the cells having undergone 22 cell doublings in culture, wherein the cells express CD90 and CD49c and one or more of sox-9, sox-11, hox-A5, and MSX-1, wherein the cell population is derived from human bone marrow.

2. The cell population of claim 1 , further expressing telomerase.

3. The cell population of claim 1 , wherein the cell population differentiates into cardiac muscle cells.

4. The cell population of claim 1 , expressing at least one trophic factor selected from the group consisting of IL-6, VEGF, MCP 1 and BDNF.

5. A pharmaceutical composition comprising the cell population of any of claims 1 - 4 .

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2024
From: ABT HOLDING COMPANY; ATHERSYS, INC.; ADVANCED BIOTHERAPEUTICS, INC.; REGENESYS BVBA; REGENESYS, LLC
To: HEALIOS K.K.
Reel/Frame 067606/0139 →
RELEASE OF SECURITY INTEREST Recorded May 29, 2024
From: HEALIOS K.K.
To: ABT HOLDING COMPANY; ATHERSYS, INC.; ADVANCED BIOTHERAPEUTICS, INC.; REGENESYS BVBA; REGENESYS, LLC
Reel/Frame 067566/0638 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Feb 1, 2024
From: ABT HOLDING COMPANY; ATHERSYS, INC.; ADVANCED BIOTHERAPEUTICS, INC.; REGENESYS BVBA; REGENESYS, LLC
To: HEALIOS K.K.
Reel/Frame 066435/0775 →